UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alemtuzumab (Campath‐1H) and Tacrolimus Monotherapy After Renal Transplantation: Results of a Prospective Randomized Trial

American journal of transplantation, 2008-07, Vol.8 (7), p.1480-1485

2008

Volltextzugriff (PDF)

Prope tolerance: the future of organ transplantation--from the laboratory to the clinic

Transplantation, 2004-03, Vol.77 (6), p.930-932

Calne, R Y

2004

Volltextzugriff (PDF)

Cyclosporine as a milestone in immunosuppression

Transplantation proceedings, 2004-03, Vol.36 (2), p.S13-S15

Calne, R

2004

Volltextzugriff (PDF)

Clinical transplantation: current problems, possible solutions

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2005-09, Vol.360 (1461), p.1797-1801

Calne, Roy

2005

Volltextzugriff (PDF)

Early Days of Liver Transplantation

American journal of transplantation, 2008-09, Vol.8 (9), p.1775-1778

Calne, R. Y.

2008

Volltextzugriff (PDF)

Immunological tolerance - the liver effect

Immunological reviews, 2000-04, Vol.174 (1), p.280-282

Calne, R. Y.

2000

Volltextzugriff (PDF)

Prope tolerance—the future of organ transplantation from the laboratory to the clinic

International immunopharmacology, 2005, Vol.5 (1), p.163-167

Calne, R.Y.

2005

Volltextzugriff (PDF)

Challenges of Organ Transplantation

Transplantation proceedings, 2005-06, Vol.37 (5), p.1979-1983

Calne, R.

2005

Volltextzugriff (PDF)

Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days

Transplantation, 2000-10, Vol.70 (7), p.989

2000

Volltextzugriff (PDF)

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study

The Lancet (British edition), 2000-08, Vol.356 (9230), p.621-627

2000

Volltextzugriff (PDF)

The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients

Kidney international, 2006-05, Vol.69 (10), p.1858-1864

2006

Volltextzugriff (PDF)

Life‐Threatening Coagulopathy Associated with Use of Campath (Alemtuzumab) in Maintenance Steroid‐Free Renal Transplant Given Before Surgery

American journal of transplantation, 2008-04, Vol.8 (4), p.884-886

2008

Volltextzugriff (PDF)

Minimisation of immunosuppression in transplantation

The Lancet (British edition), 2007-08, Vol.370 (9588), p.654-654

2007

Volltextzugriff (PDF)

Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival

Transplantation, 1995-03, Vol.59 (6), p.919-920

1995

Volltextzugriff (PDF)

Stem cell therapy for diabetes

Indian journal of endocrinology and metabolism, 2012-12, Vol.16 (Suppl 2), p.S227-S229

2012

Volltextzugriff (PDF)

Prope tolerance—the future of organ transplantation from the laboratory to the clinic

Transplant immunology, 2004-09, Vol.13 (2), p.83-86

Calne, R.Y.

2004

Volltextzugriff (PDF)

WOFIE hypothesis: some thoughts on an approach toward allograft tolerance

Transplantation proceedings, 1996-06, Vol.28 (3), p.1152-1152

Calne, R

1996

Volltextzugriff (PDF)

The future of organ transplantation: from the laboratory to the clinic

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2001-05, Vol.356 (1409), p.767-771

2001

Volltextzugriff (PDF)

Prospects for cell-based therapy

Transplantation proceedings, 2004-12, Vol.36 (10), p.3183-3187

Calne, R.Y.

2004

Volltextzugriff (PDF)

Prope tolerance: a step in the search for tolerance in the clinic

Transplantation proceedings, 2000-11, Vol.32 (7), p.2058-2059

Calne, R

2000

Volltextzugriff (PDF)

Tolerance protocols and cell transplantation: Prospects for the clinic

Transplantation proceedings, 2003-05, Vol.35 (3), p.1248-1249

Calne, R.Y

2003

Volltextzugriff (PDF)

Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome

Journal of hepatology, 1993, Vol.18 (2), p.226-234

1993

Volltextzugriff (PDF)

“Almost tolerance” in the clinic

Transplantation proceedings, 1998-11, Vol.30 (7), p.3846-3848

Calne, R

1998

Volltextzugriff (PDF)

Graft and systemic disease in long‐term survivors of liver transplantation

Hepatology (Baltimore, Md.), 1997-01, Vol.25 (1), p.195-202

1997

Volltextzugriff (PDF)

The development of immunosuppression: the rapamycin milestone

Transplantation proceedings, 2003-05, Vol.35 (3), p.S15-S17

Calne, R.Y.

2003

Volltextzugriff (PDF)

1 – 25 von 1.029

Menü

Weitere Dienste

Einstellungen

Alemtuzumab (Campath‐1H) and Tacrolimus Monotherapy After Renal Transplantation: Results of a Prospective Randomized Trial

Prope tolerance: the future of organ transplantation--from the laboratory to the clinic

Cyclosporine as a milestone in immunosuppression

Clinical transplantation: current problems, possible solutions

Early Days of Liver Transplantation

Immunological tolerance - the liver effect

Prope tolerance—the future of organ transplantation from the laboratory to the clinic

Challenges of Organ Transplantation

Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study

The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients

Life‐Threatening Coagulopathy Associated with Use of Campath (Alemtuzumab) in Maintenance Steroid‐Free Renal Transplant Given Before Surgery

Minimisation of immunosuppression in transplantation

Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival

Stem cell therapy for diabetes

Prope tolerance—the future of organ transplantation from the laboratory to the clinic

WOFIE hypothesis: some thoughts on an approach toward allograft tolerance

The future of organ transplantation: from the laboratory to the clinic

Prospects for cell-based therapy

Prope tolerance: a step in the search for tolerance in the clinic

Tolerance protocols and cell transplantation: Prospects for the clinic

Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome

“Almost tolerance” in the clinic

Graft and systemic disease in long‐term survivors of liver transplantation

The development of immunosuppression: the rapamycin milestone

Suchergebnisse filtern